AGP Picks
View all

AI genomics interpretation market seen hitting $5.99 billion by 2030

Nov. 3, 2026
AI genomics interpretation market seen hitting $5.99 billion by 2030
By AI, Created 14:15 UTC, Nov 03, 2026, AGP -

The artificial intelligence clinical genomics interpretation market is projected to grow from $1.74 billion in 2025 to $5.99 billion by 2030 as healthcare providers and drug developers lean harder on AI for precision medicine. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth through 2030.

Why it matters: - AI tools are becoming a core part of clinical genomics workflows as demand rises for personalized medicine and clinical-grade genomic reporting. - The market’s projected growth points to broader adoption of AI in precision medicine, oncology genomics, and decision-support systems. - Faster interpretation of complex genetic data can help clinicians match treatments more closely to patient profiles and reduce trial-and-error care.

What happened: - The Business Research Company published a 2026 report on the artificial intelligence clinical genomics interpretation market. - The market is estimated at $2.23 billion in 2026, up from $1.74 billion in 2025. - The report projects the market will reach $5.99 billion by 2030. - The report pegs the market’s compound annual growth rate at 28.3% from 2025 to 2026 and 28.0% through 2030.

The details: - Artificial intelligence clinical genomics interpretation uses AI algorithms and computational models to analyze genomic data for clinical use. - The technology helps identify genetic variations, assess disease risk and support personalized treatment strategies. - Growth has been driven by more genomic sequencing data, wider precision medicine programs, higher adoption of bioinformatics platforms and early AI integration into genomics workflows. - The report says future growth will also come from cloud-based interpretation platforms, predictive modeling, genomics-linked clinical decision support and customized treatment planning. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company is offering a free sample report and a full market report online: sample report and full report.

Between the lines: - The market’s growth is tied to a broader shift toward personalized care, where genomic data can guide diagnosis and treatment choices. - A February 2024 update from the Personalized Medicine Coalition said the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. - That jump suggests continued momentum for therapies that depend on genomic insight, which can reinforce demand for interpretation tools. - The regional split suggests mature infrastructure and spending in North America, while expanding healthcare access and research investment are opening room for faster growth in Asia-Pacific.

What's next: - The report expects continued expansion as more providers adopt AI-driven variant interpretation and cloud-based genomic platforms. - Oncology-related genomics applications are likely to remain a major demand driver. - Clinical teams are expected to use more predictive modeling and integrated decision-support tools in genomic analysis. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards and updated graphics.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Investor News Updates

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Investor News Updates

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.